Dayle Hacking

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.

Raymond P. Abratt, W. R. Bezwoda, Geoffrey Falkson et al. · Journal of Clinical Oncology · 1994 · 361 citations

Medicine, Oncology, Pharmacotherapy +17

Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer.

Raymond P. Abratt, W. R. Bezwoda, L. Goedhals et al. · Journal of Clinical Oncology · 1997 · 178 citations

Medicine, Oncology, Pharmacology +12

(ICORG 05-03): prospective randomized non-inferiority phase III trial comparing two radiation schedules in malignant spinal cord compression (not proceeding with surgical decompression); the quality of life analysis

K. A. Lee, Mary Dunne, Cormac Small et al. · Acta Oncologica · 2018 · 35 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Malignant pleural mesothelioma: a phase II trial with docetaxel

Daniel Vorobiof, Bernardo L. Rapoport, Martin Chasen et al. · Annals of Oncology · 2002 · 32 citations

Medicine, Oncology, Chemotherapy +12

ICORG 05-03: Prospective Randomized Non-Inferiority Phase 3 Trial Comparing Two Radiation Schedules in Malignant Spinal Cord Compression not Proceeding with Surgical Decompression

P. Thirion, Lydia O’Sullivan, A. Clayton-Lea et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 30 citations

Medicine, Radiation Oncology, Surgery +8